US proposal to halve biosimilar development costs for India’s Biocon, top exec says
US proposal to halve biosimilar development costs for India’s Biocon, top exec says By Reuters
Investing1 hrs ago11
Investing1 hrs agoUS proposal to halve biosimilar development costs for India’s Biocon, top exec says